Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Tanaka

Showing results (781-790 of 838) with videos related to

Pageof 84
Sort By:
JTO Clinical and Research Reports|March 19, 2026
Clinical Outcomes of First-Line Pembrolizumab Monotherapy in Advanced NSCLC With PD-L1 Tumor Proportion Score of 1% to 49%: A Retrospective Multicenter StudyAkito Miyazaki, Kinnosuke Matsumoto, Motohiro Tamiya, et al.
Science Signaling|May 11, 2017
Tetraspanin microdomains control localized protein kinase C signaling in B cellsMalou Zuidscherwoude, Vera-Marie E Dunlock, Geert van den Bogaart, et al.
BMC Gastroenterology|May 1, 2026
Improvement of hepatic reserve and changes in liver and spleen volume after balloon-occluded retrograde transvenous obliterationKazuma Shinkai, Ryotaro Sakamori, Ryoko Yamada, et al.
Cancers|July 27, 2022
Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination ImmunotherapyTakayuki Matsumae, Takahiro Kodama, Yuta Myojin, et al.
Nature Communications|March 18, 2023
Insights into the formation and evolution of extraterrestrial amino acids from the asteroid RyuguChristian Potiszil, Tsutomu Ota, Masahiro Yamanaka, et al.
Thoracic Cancer|June 3, 2026
Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicenter Retrospective StudyKeijiro Yamauchi, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.
Circulation|August 24, 2014
CD82 restrains pathological angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cellsQuan Wei, Feng Zhang, Mekel M Richardson, et al.
JAMA Network Open|February 5, 2025
Cognitive Processing Therapy for Posttraumatic Stress Disorder in Japan: A Randomized Clinical TrialMasaya Ito, Akiko Katayanagi, Mitsuhiro Miyamae, et al.
Cancers|October 14, 2022
The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver FunctionHideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, et al.
Hepatology (Baltimore, Md.)|January 15, 2026
NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinomaShuhei Yamamoto, Takahiro Kodama, Akifumi Kuwano, et al.
Pageof 84

Showing results (781-790 of 838) with videos related to

Sort By:
Pageof 84
JTO Clinical and Research Reports|March 19, 2026
Clinical Outcomes of First-Line Pembrolizumab Monotherapy in Advanced NSCLC With PD-L1 Tumor Proportion Score of 1% to 49%: A Retrospective Multicenter StudyAkito Miyazaki, Kinnosuke Matsumoto, Motohiro Tamiya, et al.
Science Signaling|May 11, 2017
Tetraspanin microdomains control localized protein kinase C signaling in B cellsMalou Zuidscherwoude, Vera-Marie E Dunlock, Geert van den Bogaart, et al.
BMC Gastroenterology|May 1, 2026
Improvement of hepatic reserve and changes in liver and spleen volume after balloon-occluded retrograde transvenous obliterationKazuma Shinkai, Ryotaro Sakamori, Ryoko Yamada, et al.
Cancers|July 27, 2022
Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination ImmunotherapyTakayuki Matsumae, Takahiro Kodama, Yuta Myojin, et al.
Nature Communications|March 18, 2023
Insights into the formation and evolution of extraterrestrial amino acids from the asteroid RyuguChristian Potiszil, Tsutomu Ota, Masahiro Yamanaka, et al.
Thoracic Cancer|June 3, 2026
Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicenter Retrospective StudyKeijiro Yamauchi, Kinnosuke Matsumoto, Takayuki Shiroyama, et al.
Circulation|August 24, 2014
CD82 restrains pathological angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cellsQuan Wei, Feng Zhang, Mekel M Richardson, et al.
JAMA Network Open|February 5, 2025
Cognitive Processing Therapy for Posttraumatic Stress Disorder in Japan: A Randomized Clinical TrialMasaya Ito, Akiko Katayanagi, Mitsuhiro Miyamae, et al.
Cancers|October 14, 2022
The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver FunctionHideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, et al.
Hepatology (Baltimore, Md.)|January 15, 2026
NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinomaShuhei Yamamoto, Takahiro Kodama, Akifumi Kuwano, et al.
Pageof 84